EMC Instytut Medyczny S.A. — Clinical Trial Site

87 Registered trials

42 Currently recruiting

Organisation

EMC Instytut Medyczny S.A.

Location

Wroclaw, Poland

Identifier

ORG-100043878

Address

Ul. Pilczycka 144/148, 54-144, Poland

Departments

"Certus" Private Healthcare Facility Hospital No. 1
"EMC Instytut Medyczny SA PL Certus Szpital Nr 1 PL Certus Ambulatorium"
Certus Szpital Nr 1, PL Certus Ambulatorium
Clinic Specialist
Clinical Trial
Dermatology
EuroMediCare Przychodnia Specjalistyczna we Wrocławiu
EuroMediCare Specialist Outpatient Clinics in Wroclaw
EuroMediCare Szpital Specjalistyczny z Przychodnią
EuroMediCare Szpital Specjalistyczny, Przychodnia Specjalistyczna we Wrocławiu
EuroMediCare Wrocław Wejherowska
Gastroenterology
N/A
NA
Neurolgy
Penta Hospitals Przychodnie
Penta Hospitals Przychodnie, Wroclaw Wejherowska
Penta Hospitals Przychodnie, Wrocław Wejherowska
PL Certus Ambulatorium
PL Certus Szpital nr 1 , PL Certus Ambulatorium
PL Certus Szpital Nr 1 PL Certus Ambulatoria
PL Certus Szpital Nr 1 PL Certus Ambulatorium
PL Certus Szpital Nr 1, PL Certus Ambulatoria
PL Certus Szpital Nr 1, PL Certus Ambulatorium
PL10003: EuroMediCare Szpital Specjalistyczny z Przychodnia
PL10013: EuroMediCare Szpital Specjalistyczny z Przychodnia
PL10053:EuroMediCare Szpital Specjalistyczny z Przychodnia
Prywatna Lecznica "Certus" Szpital Nr 1
Prywatna Lecznica "Certus" Szpital Nr 1, Prywatna Lecznica Certus Ambulatoria
Prywatna Lecznica "Certus" Szpital Nr 1; Prywatna Lecznica Certus Ambulatoria
Prywatna Lecznica “Certus” Szpital Nr 1
Prywatna Lecznica „Certus” Szpital Nr 1
Prywatna Lecznica „Certus” Szpital Nr 1, Prywatna Lecznica Certus Ambulatoria
Prywatna Lecznica Certus – Szpital i Ambulatorium
Prywatna Lecznica CERTUS Szpital 1 Prywatna Lecznica CERTUS Ambulatoria
Prywatna Lecznica Certus Szpital Nr 1, Prywatna Lecznica Certus Ambulatorium
Przychodnia EuroMediCare .Here patient will be seen, and clinical trial will take place.
Przychodnia EuroMediCare Szpital Specjalistyczny z Przychodnią
Przychodnia EuroMediCare, Wrocław Łowiecka
Przychodnia Specjalistyczna
Site:Prywatna Lecznica "Certus" Szpital Nr1; PL Certus Ambulatoria, Grunwaldzka 156,60-309 Poznań
ul. Łowiecka 24, 50-220 Wrocław, Przychodnia EuroMediCare, Wrocław Łowiecka
Unknown
Urology

Clinical trials at this site (87)

Search interface

Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers Ended

2023-508177-85-00 Healthy volunteers (Meningococcal infection) 5 2024-03-12
This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adu… Ended

2023-504799-94-00 Chronic Spontaneous Urticaria 4 2024-02-20
Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-504673-20-00 Ulcerative Colitis 4 2023-12-06
To access the effect of SCD-044 in treatment of moderate to severe atopic dermatitis Ended

2024-511615-16-00 atopic dermatitis 4 2023-08-25
Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis Ended

2023-506046-24-00 Ulcerative Colitis (UC) 4 2023-07-03
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-511089-36-00 Crohn’s disease 4 2023-03-17
A study to learn how well the drug EDP-938 works and how safe it is for non-hospitalized Adults with Acute Respiratory Syncytial Virus Infec… Ended

2024-513861-38-00 Respiratory syncytial virus (RSV) 4 2023-02-02
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Radiological and Clinical Effects of Subcutaneous (SC) Ocrelizumab… Ended

2023-505975-54-00 Multiple Sclerosis (MS) 5 2022-03-28
Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Colitis Ended

2023-506004-93-00 Ulcerative Colitis (UC) 4 2022-03-01
VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis Ended

2023-509233-39-00 Moderately to Severely Active Ulcerative Colitis 4 2022-01-20
Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NA… Ended

2023-506961-74-00 Non-alcoholic steatohepatitis (NASH) 4 2021-08-31
Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGROLT) Ended

2023-509801-59-00 Alopecia areata 5 2020-07-09
A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoria… Ended

2023-508992-35-00 Plaque Psoriasis 4
A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to … Ended

2025-522750-39-00 Erosive esophagitis (EE) due to gastroesophageal reflux 5